NOVOPHAGE
Novophage is providing the biological solutions for industrial infrastructure problems. Biofilms, slimy communities of bacteria, prevent heat transfer, cause massive corrosion, biofouling and diseases, while costing the US economy in the double-digit billion dollar figures. Current approaches to combat these persistent problems are either toxic, corrosive and/or environmentally damaging. Novophage is developing a first-in-class anti-biofilm solution that is green and highly effective against bio... films. Enabled by their expertise in synthetic biology and systems biology, their patent-pending solution utilizes a biological nanoparticle that leverages biofilm bacteria’s own machinery to create active agents that act against the biofilm itself. This approach can be combined with existing antimicrobials to increase energy efficiency in heat transfer systems and prolong the lifetime of valuable infrastructure.
NOVOPHAGE
Industry:
Biotechnology Industrial Information Technology Infrastructure Renewable Energy
Founded:
2009-01-01
Address:
Boston, Massachusetts, United States
Country:
United States
Website Url:
http://www.novophage.com
Total Employee:
11+
Status:
Closed
Total Funding:
5.75 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible GoDaddy DNS Google Google Cloud OpenResty Google Adsense Google Cloud Global Multi-Region AdBlock Acceptable Ads Google Adsense For Domains
Founder
Investors List
MassChallenge
MassChallenge investment in Grant - Novophage
Official Site Inspections
http://www.novophage.com
- Host name: a2aa9ff50de748dbe.awsglobalaccelerator.com
- IP address: 3.33.130.190
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
More informations about "Novophage"
Novophage - Crunchbase Company Profile & Funding
Novophage is providing the biological solutions for industrial infrastructure problems. Biofilms, slimy communities of bacteria, prevent heat transfer, cause massive corrosion, biofouling and …See details»
Michael Koeris' Journey from Grad Student to …
After a brief stint at the venture capital firm, Flagship Ventures, Koeris helped change Novophage's focus. The company went from developing therapeutics to developing phage-based tools for detecting pathogens in food products. Along …See details»
Novophage - LinkedIn
Jul 1, 2022 · Novophage is a fast growing startup company at the intersection of Food and Biotech. Novophage, based in Boston, recently took in over $5M in funding from some of the …See details»
Novophage - Funding, Financials, Valuation & Investors
Novophage is providing the biological solutions for industrial infrastructure problems.See details»
Novophage Financial Overview, Employee Count, and Competitors
View Novophage (http://www.novophage.com) location in Massachusetts, United States, revenue, competitors and contact information. Find and reach Novophage's employees by department, …See details»
Brighter future for bacteria detection - MIT News
Mar 20, 2014 · They funded their company, then called Novophage, through university business-plan competitions across the country, and outfitted nearly an entire lab with reused equipment from MIT and auctions. Faced with the …See details»
Sample6 - Crunchbase Company Profile & Funding
Sample6 is a synthetic-biology based bacteria diagnostic system capable of enrichment-free detection. Its technology detects as low as 1CFU/ml in just 4 hours. Its proprietary …See details»
Novophage Company Profile: , Investments, Contact Information, …
Novophage is a fast growing startup company at the intersection of Food and Biotech. Novophage, based in Boston, recently took in over $5M in funding from some of the most …See details»
Novophage - VentureRadar
Website: http://www.novophage.com Develops first-in-class, eco-friendly anti-biofilm solution to combat biofouling, corrosion, and energy inefficiency, targeting a $2.2B market by utilizing …See details»
Novophage Asset Profile | Preqin
Novophage is based in US and operates as a biological solutions provider for industrial infrastructure problems.See details»
Biotech Start-up Wins Global Moot Corp - Inc.com
May 19, 2009 · Novophage Theraputics from Boston University hopes to market technology that slows resistence to antibiotics. With its patented new therapy to fight antibiotic resistance, a …See details»
Novophage Lands Series A Round - PE Hub
May 31, 2011 · Novophage will develop and market synthetic biology-enabled products that tackle the problems of bacterial contamination in industries such as oil and gas, pulp and paper and …See details»
Novophage - Crunchbase
Novophage is providing the biological solutions for industrial infrastructure problems.See details»
Bacterial Viruses Boost Antibiotic Action - Harvard Medical School
Apr 3, 2009 · Lu has spun off a start-up company called Novophage to begin translating this research for the clinic. He and his partners have already raised seed money by winning a …See details»
Winners & Runners-Up | New Venture Competition - Harvard …
Novophage Therapeutics will commercialize a new therapy to treat antibiotic-resistant bacterial infections that is more efficacious than current therapies using enhanced bacteriophage that …See details»
Novophage Completes $5.7M Series A Financing - FinSMEs
Novophage, a Boston, MA-based early-stage technology company that develops a new class of biologics for different industrial applications, has completed a $5.7m Series A round of financing.See details»
The next generation of bacteriophage therapy - ScienceDirect
Oct 1, 2011 · In this review, we give an overview of the current state-of-the-art of bacteriophage therapy. We review the challenges to be overcome before phage therapy can become a part …See details»
Novophage - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Novophage is providing the biological solutions for industrial infrastructure problems.See details»
Phage therapy: From biological mechanisms to future directions
Herein, we review the state of the art in phage therapy, covering biological mechanisms, clinical applications, remaining challenges, and future directions involving naturally occurring and …See details»
Home - Cytophage
Nov 11, 2024 · Our tailor-made bacteriophages are inexpensive, quick to produce, harmless to humans and animals, better for the environment and highly effective against exposed bacteria. …See details»